Annual Interest Expense
$213.00 K
+$205.00 K+2562.50%
December 31, 2023
Summary
- As of February 7, 2025, GTBP annual interest expense is $213.00 thousand, with the most recent change of +$205.00 thousand (+2562.50%) on December 31, 2023.
- During the last 3 years, GTBP annual interest expense has fallen by -$3.11 million (-93.58%).
- GTBP annual interest expense is now -97.66% below its all-time high of $9.12 million, reached on December 31, 2018.
Performance
GTBP Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, GTBP quarterly interest expense is $0.00, unchanged on September 30, 2024.
- Over the past year, GTBP quarterly interest expense has stayed the same.
- GTBP quarterly interest expense is now -100.00% below its all-time high of $4.66 million, reached on June 30, 2020.
Performance
GTBP Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, GTBP TTM interest expense is $0.00, unchanged on September 30, 2024.
- Over the past year, GTBP TTM interest expense has dropped by -$1000.00 (-100.00%).
- GTBP TTM interest expense is now -100.00% below its all-time high of $10.76 million, reached on June 30, 2018.
Performance
GTBP TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
GTBP Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2562.5% | 0.0% | -100.0% |
| 3 y3 years | -93.6% | -100.0% | -100.0% |
| 5 y5 years | -97.7% | -100.0% | -100.0% |
GTBP Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.3% | +2562.5% | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -93.6% | +2562.5% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -97.7% | +2562.5% | -100.0% | +100.0% | -100.0% | +100.0% |
GT Biopharma Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | $1000.00(-99.5%) |
| Dec 2023 | $213.00 K(+2562.5%) | $0.00(0.0%) | $213.00 K(-3.6%) |
| Sep 2023 | - | $0.00(-100.0%) | $221.00 K(0.0%) |
| Jun 2023 | - | $1000.00(-99.5%) | $221.00 K(+0.5%) |
| Mar 2023 | - | $212.00 K(+2550.0%) | $220.00 K(+2650.0%) |
| Dec 2022 | $8000.00(-98.9%) | $8000.00(>+9900.0%) | $8000.00(-63.6%) |
| Sep 2022 | - | $0.00(0.0%) | $22.00 K(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $22.00 K(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $22.00 K(-96.9%) |
| Dec 2021 | $718.00 K(-78.4%) | $22.00 K(>+9900.0%) | $718.00 K(-132.5%) |
| Sep 2021 | - | $0.00(0.0%) | -$2.21 M(+72.7%) |
| Jun 2021 | - | $0.00(-100.0%) | -$1.28 M(-137.9%) |
| Mar 2021 | - | $696.00 K(-123.9%) | $3.38 M(+1.7%) |
| Dec 2020 | $3.32 M(+56.0%) | -$2.91 M(-412.2%) | $3.32 M(-51.6%) |
| Sep 2020 | - | $931.00 K(-80.0%) | $6.86 M(+5.7%) |
| Jun 2020 | - | $4.66 M(+630.1%) | $6.49 M(+180.8%) |
| Mar 2020 | - | $638.00 K(+0.5%) | $2.31 M(+8.6%) |
| Dec 2019 | $2.13 M(-76.7%) | $635.00 K(+13.4%) | $2.13 M(-19.1%) |
| Sep 2019 | - | $560.00 K(+16.9%) | $2.63 M(-17.6%) |
| Jun 2019 | - | $479.00 K(+5.5%) | $3.19 M(-51.9%) |
| Mar 2019 | - | $454.00 K(-60.1%) | $6.64 M(-27.2%) |
| Dec 2018 | $9.12 M(+6.0%) | $1.14 M(+1.4%) | $9.12 M(+12.4%) |
| Sep 2018 | - | $1.12 M(-71.4%) | $8.11 M(-24.6%) |
| Jun 2018 | - | $3.92 M(+33.9%) | $10.76 M(+34.3%) |
| Mar 2018 | - | $2.93 M(+2071.1%) | $8.01 M(+57.7%) |
| Dec 2017 | $8.60 M(+31.2%) | $135.00 K(-96.4%) | $5.08 M(-24.4%) |
| Sep 2017 | - | $3.77 M(+219.9%) | $6.72 M(+49.8%) |
| Jun 2017 | - | $1.18 M(-33.6%) | $4.49 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $6.55 M(+448.1%) | $1.77 M(+15.5%) | $4.91 M(+56.6%) |
| Sep 2016 | - | $1.54 M(-3.9%) | $3.13 M(-5.7%) |
| Jun 2016 | - | $1.60 M(-7.3%) | $3.32 M(+29.1%) |
| Sep 2015 | - | $1.72 M(+103.1%) | $2.57 M(-37.4%) |
| Jun 2015 | - | $849.00 K(-74.0%) | $4.11 M(+7.6%) |
| Sep 2014 | - | $3.26 M(+1842.3%) | $3.82 M(+393.8%) |
| Jun 2014 | - | $168.00 K(-14.7%) | $774.00 K(-10.2%) |
| Mar 2014 | - | $197.00 K(+1.5%) | $862.00 K(-27.9%) |
| Dec 2013 | $1.20 M(+115.1%) | $194.00 K(-9.8%) | $1.20 M(+19.4%) |
| Sep 2013 | - | $215.00 K(-16.0%) | $1.00 M(+17.6%) |
| Jun 2013 | - | $256.00 K(-51.8%) | $852.00 K(-51.6%) |
| Mar 2013 | - | $531.00 K(+716.9%) | $1.76 M(+26.2%) |
| Sep 2012 | - | $65.00 K(-94.4%) | $1.40 M(-3.6%) |
| Jun 2012 | - | $1.17 M(+1475.7%) | $1.45 M(+213.4%) |
| Mar 2012 | - | $74.00 K(-18.7%) | $462.00 K(-16.9%) |
| Dec 2011 | $556.00 K(+8.4%) | $91.00 K(-22.2%) | $556.00 K(0.0%) |
| Sep 2011 | - | $117.00 K(-35.0%) | $556.00 K(+20.3%) |
| Jun 2011 | - | $180.00 K(+7.1%) | $462.00 K(+57.1%) |
| Mar 2011 | - | $168.00 K(+84.6%) | $294.00 K(-43.7%) |
| Dec 2010 | $513.00 K(-54.8%) | $91.00 K(+295.7%) | $522.00 K(-55.9%) |
| Sep 2010 | - | $23.00 K(+91.7%) | $1.18 M(-8.7%) |
| Jun 2010 | - | $12.00 K(-97.0%) | $1.30 M(-9.7%) |
| Mar 2010 | - | $396.00 K(-47.3%) | $1.44 M(+26.4%) |
| Dec 2009 | $1.14 M(-31.4%) | $752.00 K(+452.9%) | $1.14 M(+155.9%) |
| Sep 2009 | - | $136.00 K(-10.5%) | $444.00 K(-68.1%) |
| Jun 2009 | - | $152.00 K(+58.3%) | $1.39 M(-6.8%) |
| Mar 2009 | - | $96.00 K(+60.0%) | $1.50 M(-9.7%) |
| Dec 2008 | $1.66 M | $60.00 K(-94.5%) | $1.66 M(+3.8%) |
| Sep 2008 | - | $1.09 M(+327.6%) | $1.60 M(+212.5%) |
| Jun 2008 | - | $254.00 K(-1.2%) | $511.00 K(+98.8%) |
| Mar 2008 | - | $257.00 K | $257.00 K |
FAQ
- What is GT Biopharma annual interest expense?
- What is the all time high annual interest expense for GT Biopharma?
- What is GT Biopharma annual interest expense year-on-year change?
- What is GT Biopharma quarterly interest expense?
- What is the all time high quarterly interest expense for GT Biopharma?
- What is GT Biopharma quarterly interest expense year-on-year change?
- What is GT Biopharma TTM interest expense?
- What is the all time high TTM interest expense for GT Biopharma?
- What is GT Biopharma TTM interest expense year-on-year change?
What is GT Biopharma annual interest expense?
The current annual interest expense of GTBP is $213.00 K
What is the all time high annual interest expense for GT Biopharma?
GT Biopharma all-time high annual interest expense is $9.12 M
What is GT Biopharma annual interest expense year-on-year change?
Over the past year, GTBP annual interest expense has changed by +$205.00 K (+2562.50%)
What is GT Biopharma quarterly interest expense?
The current quarterly interest expense of GTBP is $0.00
What is the all time high quarterly interest expense for GT Biopharma?
GT Biopharma all-time high quarterly interest expense is $4.66 M
What is GT Biopharma quarterly interest expense year-on-year change?
Over the past year, GTBP quarterly interest expense has changed by $0.00 (0.00%)
What is GT Biopharma TTM interest expense?
The current TTM interest expense of GTBP is $0.00
What is the all time high TTM interest expense for GT Biopharma?
GT Biopharma all-time high TTM interest expense is $10.76 M
What is GT Biopharma TTM interest expense year-on-year change?
Over the past year, GTBP TTM interest expense has changed by -$1000.00 (-100.00%)